Only 34 days until CPHI Milan 2024! Our BD Manager Kasia Niemiec and other members of the MedPharm team will be in attendance. Stop by our booth 7B99, or reach out through our website to schedule a meeting with the team: https://lnkd.in/dB2CPJ-Y Informa #CPHI #CPHIMilan #CPHI35Years #AtTheHeartOfPharma
MedPharm
Pharmaceutical Manufacturing
Guildford, Surrey 14,182 followers
Breaking through boundaries
About us
Getting a promising new topical or transepithelial product from lab to patient is challenging. Making it all the way through the development pipeline will be time-consuming, risky, and unpredictable. That’s why it makes sense to think ahead and partner with the experts who can give pharma companies like yours more opportunities for success, every step of the way. As a global CDMO focused only on topical and transepithelial delivery methods, MedPharm has the proven ability to understand and anticipate the needs of our partners—even in the face of market changes, regulatory environments, or scientific advancements. Whether through our robust and innovative research methods, clinical trial material manufacturing, or full-scale commercial production, you can entrust every aspect of your drug pipeline to MedPharm—the global gold standard in topical and transepithelial CDMO services.
- Website
-
http://www.medpharm.com
External link for MedPharm
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Guildford, Surrey
- Type
- Privately Held
- Specialties
- Topical and transdermal formulation development, GMP Clinical Trial Supply manufacture, and Topical and transdermal drug delivery technology
Locations
-
Primary
Unit 3 Chancellor Court
50 Occam Road
Guildford, Surrey GU2 7YN, GB
-
4222 Emperor Blvd
Durham, North Carolina 27703, US
-
4018 Stirrup Creek Dr
Durham, North Carolina 27703, US
Employees at MedPharm
Updates
-
The countdown to CPHI Milan continues! In less than TWO WEEKS MedPharm BD Manager, Kasia Niemiec, will attend the show along with Charles Evans, our SVP of Pharmaceutical Development and other MedPharm team members. Reach out to us in the platform or through our website to schedule a meeting during the event. And be sure to stop by Booth 7B99 to say hi to the team during the show! https://hubs.la/Q02Pw3fJ0 Informa #CPHIMilan #CPHI35Years
-
Happening this week! Stop by table #62 at Contract Pharma Contracting & Outsourcing Conference to catch up with the MedPharm team. Comment below if we'll see you there. ⬇️⬇️
-
MedPharm's Senior BD Director, Tim Miley, will be in New Brunswick, NJ on September 26th for the Contract Pharma Contracting & Outsourcing Conference! Stop by MedPharm's table #62 during the show, or schedule a meeting with Tim through our website: https://hubs.la/Q02Pv_J00
-
#ICYMI... We recently announced that MedPharm and Tergus have joined forces to establish the best-in-class end-to-end CDMO specializing in topical and transepithelial drug products. Read the full announcement or reach to us today for more information: https://lnkd.in/ee-AK72G
-
MedPharm reposted this
🎉 Exciting news from our valued sponsors! Congratulations to MedPharm Ltd and Tergus Pharma, two leading CDMO organizations, on their merger. 👉 Check out the press release here: https://lnkd.in/ee-AK72G
-
MedPharm reposted this
MedPharm Ltd, an Ampersand Capital Partners portfolio company, has merged with Tergus Pharma. Operating under the MedPharm name, the newly combined company forms a leading topical and transdermal CDMO providing a full suite of drug development and manufacturing services. https://lnkd.in/ev3XqJCN
-
MedPharm is excited to announce that we are joining forces with Tergus Pharma to create the best-in-class end-to-end topical and transepithelial CDMO. Michael Kane has been appointed CEO of the merged company, which will operate under the MedPharm name. Michael previously served as the CEO of Tergus. MedPharm will continue delivering the gold standard in topical development to pharmaceutical developers around the globe, from pre-clinical R&D to Phase II manufacturing, including our industry-leading in vitro testing services. This merger adds full commercial production capabilities to MedPharm’s portfolio of services, including high-potency and hormone-based drugs and comprehensive serialization. With locations in the U.K. and the U.S., the expanded end-to-end capabilities and continued commitment to innovation and research uniquely position MedPharm as the premier CDMO focused on topical and transepithelial drug products. Click here to learn more: https://hubs.la/Q02FB3yc0
-
MedSpray® is a patented aerosol formulation technology, known as a “patch-in-a-can,” developed by our experts for a range of applications. When combined with your API, the MedSpray® technology allows for a safer, more effective, and superior finished drug product. Visit our website to learn more about the advantages of MedSpray® today: https://lnkd.in/ebCEViDw #innovation #drugdevelopment #technology #respiratory
-
Bio International is in full swing!! Reach out to us through the platform or our website to catch up with Scott and Evan this week.
Only one more week until our team heads to Bio International! Scott Klepfer and Evan Andrews will be in San Diego June 3rd-6th to catch up with everyone. If you're interested in meeting with the team to discuss how MedPharm can support your ongoing programs, message us through the partnering platform or our website >> https://lnkd.in/eCkSm2e7 Biotechnology Innovation Organization #BIO2024